FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Enoxaparin Sodium Injection
Status: Discontinuation
»Therapeutic Categories: Hematology

Expand all

Teva Pharmaceuticals (New 01/28/2021)

Company Contact Information:
800-545-8800

Presentation Posting Date Related Information
30 mg/0.3mL (NDCs 0703-8530-21 and 0703-8530-23) 01/28/2021 Product expected to be available until December 2021
40 mg/0.4 mL (NDCs 0703-8540-21 and 0703-8540-23) 01/28/2021 Product expected to be available until October 2021
60 mg/0.6 mL (NDCs 0703-8560-21 and 0703-8560-23) 01/28/2021 Product expected to be available until December 2021
80 mg/0.8 mL (NDCs 0703-8680-21 and 0703-8680-23) 01/28/2021 Product expected to be available until December 2021
100 mg/1 mL (NDCs 0703-8580-21 and 0703-8580-23) 01/28/2021 Product expected to be available until December 2021
120 mg/0.8 mL (NDCs 0703-8610-21 and 0703-8610-23) 01/28/2021 Product expected to be available until August 2021
150 mg/1 mL (NDCs 0703-8510-21 and 0703-8510-23) 01/28/2021 Product expected to be available until December 2021

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English